Hepatitis B surface antigen (HBsAg) prevalence (%) in Eritrea
Eritrea: Hepatitis B surface antigen (HBsAg) prevalence was 0.5% in 2024. ▼ Falling
Hepatitis B surface antigen (HBsAg) prevalence in Eritrea, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Eritrea recorded 0.5% for hepatitis b surface antigen (hbsag) prevalence in 2024. That is the lowest value across all 10 years on record.
Compared with earlier readings it is down 16.7% on the previous year and down 28.6% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Eritrea peaked at 0.7% in 2015 and was at its lowest, 0.5%, in 2024.
That places Eritrea 59th out of 194 countries with data for 2024, putting it in the middle of the range.
Hepatitis B surface antigen (HBsAg) prevalence in Eritrea, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 0.7% | — |
| 2016 | 0.6% | -14.3% |
| 2017 | 0.6% | +0.0% |
| 2018 | 0.6% | +0.0% |
| 2019 | 0.6% | +0.0% |
| 2020 | 0.6% | +0.0% |
| 2021 | 0.6% | +0.0% |
| 2022 | 0.6% | +0.0% |
| 2023 | 0.6% | +0.0% |
| 2024 | 0.5% | -16.7% |
Eritrea compared with similar countries
- Eritrea's 0.5% is below the median for low income countries, which is 0.7%, 71% of the median. (25 countries reporting)
- Eritrea's 0.5% is below the median for Sub-Saharan Africa, which is 1.1%, 48% of the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.6% | 0.6% | 0.7% | 5 |
| 2020s | 0.6% | 0.5% | 0.6% | 5 |
Countries ranked near Eritrea
More health data for Eritrea
- Un projection of annual infant deaths, annual growth rate -1.62 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.2 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 821.1 deaths per 1,000 people (2090)
- Number of infants who die before age 1 425 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 1.72 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2011)
- Population ages 00-04, female, per capita 0.0652 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.73 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2011)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Eritrea?
- Hepatitis b surface antigen (hbsag) prevalence in Eritrea was 0.5% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Eritrea?
- The highest recorded value was 0.7% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Eritrea?
- The lowest recorded value was 0.5% in 2024.
- How does Eritrea rank for hepatitis b surface antigen (hbsag) prevalence?
- Eritrea ranks 59th out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Eritrea?
- Over the last ten years it is down 28.6%. The long-run trend across the full record is falling.
- Where does this Eritrea data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).